{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:44:34Z","timestamp":1794851074898,"version":"4.9.1"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVES<\/jats:title><jats:p>We aimed to study whether national and local antibiotic stewardship projects have reduced the antibiotic use in newborns and to monitor potential changes in adverse outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>In a nationwide, population-based study from Norway, we included all hospital live births from 34 weeks' gestation (n = 282\u2009046) during 2015 to 2019. The primary outcome was the proportion of newborns treated with antibiotics from 0 to 28 days after birth. The secondary outcomes were the overall duration of antibiotic treatment and by categories: culture-positive sepsis, clinical sepsis, and no sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>A total of 7365 (2.6%) newborns received intravenous antibiotics during the period, with a reduction from 3.1% in 2015 to 2.2% in 2019 (30% decrease; P &amp;lt; .001). Hospitals with antibiotic stewardship projects experienced the largest reduction (48% vs 23%; P &amp;lt; .001). We found a small decrease in the median duration of antibiotic treatment in newborns without sepsis from 2.93 to 2.66 days (P = .011), and geographical variation was reduced during the study period. The overall number of days with antibiotic treatments was reduced by 37% from 2015 to 2019 (119.1 of 1000 vs 75.6 of 1000; P &amp;lt; .001). Sepsis was confirmed by blood culture in 206 newborns (incidence rate: 0.73 cases per 1000 live births). We found no increase in sepsis with treatment onset &amp;gt;72 hours of life, and sepsis-attributable deaths remained at a low level.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>During the study period, a substantial decrease in the proportion of newborns treated with antibiotics was observed together with a decline in treatment duration for newborns without culture-positive sepsis.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2021-051339","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:17:33Z","timestamp":1637713053000},"source":"Crossref","is-referenced-by-count":22,"title":["Antibiotic Use in Term and Near-Term Newborns"],"prefix":"10.1542","volume":"148","author":[{"given":"H\u00e5kon Stangeland","family":"Mundal","sequence":"first","affiliation":[{"name":"Paediatric Department, Ostfold Hospital Trust, Gr\u00e5lum, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild","family":"R\u00f8nnestad","sequence":"additional","affiliation":[{"name":"NICU, Clinic of Pediatric and Adolescent Medicine"},{"name":"Neonatal Clinical and Epidemiological Research Group, Oslo University Hospital, Oslo, Norway"},{"name":"Institute of Clinical Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Klingenberg","sequence":"additional","affiliation":[{"name":"Paediatric Research Group, Faculty of Health Sciences, University of Troms\u00f8-The Arctic University of Norway, Troms\u00f8, Norway"},{"name":"Department of Paediatrics, University Hospital of North Norway, Troms\u00f8, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J\u00f8rgen","family":"Stensvold","sequence":"additional","affiliation":[{"name":"NICU, Clinic of Pediatric and Adolescent Medicine"},{"name":"Neonatal Clinical and Epidemiological Research Group, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketil","family":"St\u00f8rdal","sequence":"additional","affiliation":[{"name":"NICU, Clinic of Pediatric and Adolescent Medicine"},{"name":"Pediatric Research Institute, Faculty of Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"5","key":"2021121010411491800_B1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1542\/peds.2010-2217","article-title":"Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues","volume":"127","author":"Stoll","year":"2011","journal-title":"Pediatrics"},{"issue":"10104","key":"2021121010411491800_B2","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0140-6736(17)31002-4","article-title":"Neonatal sepsis","volume":"390","author":"Shane","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"2021121010411491800_B3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jac\/dkx426","article-title":"Antibiotic therapy in neonates and impact on gut microbiota and antibiotic resistance development: a systematic review","volume":"73","author":"Fjalstad","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2021121010411491800_B4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/oby.22747","article-title":"Impact of exposure to antibiotics during pregnancy and infancy on childhood obesity: a systematic review and meta-analysis","volume":"28","author":"Wan","year":"2020","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"2021121010411491800_B5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1542\/peds.2010-2092","article-title":"Prenatal or early-life exposure to antibiotics and risk of childhood asthma: a systematic review","volume":"127","author":"Murk","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"2021121010411491800_B6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/jac\/dkx088","article-title":"Antibiotic exposure in neonates and early adverse outcomes: a systematic review and meta-analysis","volume":"72","author":"Esaiassen","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2021121010411491800_B7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"1","key":"2021121010411491800_B8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41467-020-20495-4","article-title":"Neonatal antibiotic exposure impairs child growth during the first six years of life by perturbing intestinal microbial colonization","volume":"12","author":"Uzan-Yulzari","year":"2021","journal-title":"Nat Commun"},{"key":"2021121010411491800_B9","unstructured":"World Health Organization . Global action plan on antimicrobial resistance. Available at: https:\/\/www.euro.who.int\/en\/health-topics\/disease-prevention\/antimicrobial-resistance\/policy\/global-action-plan-2015. Accessed June 22, 2021"},{"key":"2021121010411491800_B10","unstructured":"Norwegian Ministry of Health and Care Services . National Strategy against antibiotic resistance 2015\u20132020. Available at: https:\/\/www.regjeringen.no\/contentassets\/5eaf66ac392143b3b2054aed90b85210\/antibiotic-resistance-engelsk-lavopploslig-versjon-for-nett-10-09-15.pdf. Accessed June 22, 2021"},{"issue":"9832","key":"2021121010411491800_B11","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"2021121010411491800_B12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/INF.0000000000000542","article-title":"Prospective surveillance of antibiotic use in the neonatal intensive care unit: results from the SCOUT study","volume":"34","author":"Cantey","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2021121010411491800_B13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0b013e3181b12484","article-title":"Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 step campaign to prevent antimicrobial resistance","volume":"28","author":"Patel","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"2021121010411491800_B14","unstructured":"Moen\u2008A, Ronnestad\u2008AE, Stensvold\u2008HJ, Uleberg\u2008B, Olsen\u2008F, Byhring\u2008HS. The Norwegian Neonatal Healthcare Atlas, 2009-2014. Available at: https:\/\/helseatlas.no\/sites\/default\/files\/norwegian-neonatal-healthcare.pdf. Accessed June 22, 2021"},{"issue":"6","key":"2021121010411491800_B15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1034\/j.1600-0412.2000.079006435.x","article-title":"The medical birth registry of Norway. Epidemiological research and surveillance throughout 30 years","volume":"79","author":"Irgens","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"2021121010411491800_B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/INF.0000000000000906","article-title":"Early-onset sepsis and antibiotic exposure in term infants: a nationwide population-based study in Norway","volume":"35","author":"Fjalstad","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2021121010411491800_B17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1403494819859737","article-title":"The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: research potential of two nationwide health-care registries","volume":"48","author":"Bakken","year":"2020","journal-title":"Scand J Public Health"},{"key":"2021121010411491800_B18","unstructured":"Macsali\u2008F, Engjom\u2008H, Stangenes\u2008K, Klungs\u00f8yr\u2008K, J\u00fal\u00edusson\u2008P, Askeland\u2008O. 2020-numbers from the Medical Birth Registry. Available at: https:\/\/www.fhi.no\/hn\/helseregistre-og-registre\/mfr\/2020-tallene-fra-medisinsk-fodselsregister\/. Accessed June 22, 2021"},{"key":"2021121010411491800_B19","unstructured":"Nakstad\u2008B, Lang\u2008A, Solevag\u2008A, Klingenberg\u2008C. Neonatale diagnosekoder i ICD-10. Available at: https:\/\/www.helsebiblioteket.no\/retningslinjer\/nyfodtmedisin\/neonatale-diagnosekoder-i-icd-10. Accessed June 22, 2021"},{"key":"2021121010411491800_B20","unstructured":"Norwegian Society of Pediatricians . Unng\u00e5 \u00e5 fortsette antibiotikabehandling hos nyf\u00f8dte etter 36-48 timer dersom ingen vekst i blodkultur og fredelig klinikk. Available at: https:\/\/www.legeforeningen.no\/kloke-valg\/anbefalinger\/fagmedisinske-anbefalinger\/norsk-barnelegeforening\/1.antibiotika-til-nyfodte-bor-avsluttes-etter-36-48-timer-dersom-ingen-vekst-i-blodkultur-og-fredelig-klinikk\/. Accessed June 22, 2021"},{"issue":"6","key":"2021121010411491800_B21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/apa.15202","article-title":"Active antibiotic discontinuation in suspected but not confirmed early-onset neonatal sepsis-A quality improvement initiative","volume":"109","author":"Dretvik","year":"2020","journal-title":"Acta Paediatr"},{"issue":"5","key":"2021121010411491800_B22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/INF.0000000000002590","article-title":"Reduced antibiotic exposure by serial physical examinations in term neonates at risk of early-onset sepsis","volume":"39","author":"Vatne","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2021121010411491800_B23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/apa.14578","article-title":"Serum concentrations of C-reactive protein in healthy term-born Norwegian infants 48-72 hours after birth","volume":"108","author":"Mjelle","year":"2019","journal-title":"Acta Paediatr"},{"issue":"2","key":"2021121010411491800_B24","doi-asserted-by":"crossref","first-page":"F163","DOI":"10.1136\/archdischild-2016-312506","article-title":"C reactive protein in healthy term newborns during the first 48 hours of life","volume":"103","author":"Perrone","year":"2018","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2021121010411491800_B25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fped.2018.00285","article-title":"Culture-negative early-onset neonatal sepsis - at the crossroad between efficient sepsis care and antimicrobial stewardship","volume":"6","author":"Klingenberg","year":"2018","journal-title":"Front Pediatr"},{"issue":"3","key":"2021121010411491800_B26","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/jp.2012.96","article-title":"Neonatal early-onset sepsis evaluations among well-appearing infants: projected impact of changes in CDC GBS guidelines","volume":"33","author":"Mukhopadhyay","year":"2013","journal-title":"J Perinatol"},{"key":"2021121010411491800_B27","unstructured":"National Institute for Health and Care Excellence (NICE) . Neonatal infection (early onset): antibiotics for prevention and treatment. Available at: https:\/\/www.nice.org.uk\/guidance\/cg149. Accessed June 22, 2021"},{"issue":"2","key":"2021121010411491800_B28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/archdischild-2018-316777","article-title":"Screening for early onset neonatal sepsis: NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population","volume":"105","author":"Goel","year":"2020","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021121010411491800_B29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamapediatrics.2016.4678","article-title":"A quantitative, risk-based approach to the management of neonatal early-onset sepsis","volume":"171","author":"Kuzniewicz","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"11","key":"2021121010411491800_B30","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamapediatrics.2019.2825","article-title":"Association of use of the neonatal early-onset sepsis calculator with reduction in antibiotic therapy and safety: a systematic review and meta-analysis","volume":"173","author":"Achten","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2021121010411491800_B31","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.eclinm.2019.11.020","article-title":"Sensitivity of the Kaiser Permanente early-onset sepsis calculator: a systematic review and meta-analysis","volume":"19","author":"Pettinger","year":"2019","journal-title":"EClinicalMedicine"},{"key":"2021121010411491800_B32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2021.01.065","article-title":"Stratification of culture-proven early-onset sepsis cases by the neonatal early-onset sepsis calculator: an individual patient data meta-analysis","volume":"234","author":"Achten","year":"2021","journal-title":"J Pediatr"},{"issue":"12","key":"2021121010411491800_B33","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1111\/1471-0528.14821","article-title":"Prevention of early-onset neonatal group B streptococcal disease. Green-top guideline no. 36","volume":"124","year":"2017","journal-title":"BJOG"},{"key":"2021121010411491800_B34","unstructured":"Brigtsen\u2008A, Oian\u2008P, Sanda\u2008B, Findal\u2008G, Rolfsen\u2008A. Gruppe B streptokokker hos gravide og f\u00f8dende (GBS). Available at: https:\/\/www.legeforeningen.no\/foreningsledd\/fagmed\/norsk-gynekologisk-forening\/veiledere\/veileder-i-fodselshjelp\/gruppe-b-streptokokker-hos-gravide-og-fodende\/. Accessed June 22, 2021"},{"issue":"6","key":"2021121010411491800_B35","doi-asserted-by":"crossref","first-page":"e20182894","DOI":"10.1542\/peds.2018-2894","article-title":"Management of neonates born at &gt;\/=35 0\/7 weeks\u2019 gestation with suspected or proven early-onset bacterial sepsis","volume":"142","author":"Puopolo","year":"2018","journal-title":"Pediatrics"},{"issue":"2","key":"2021121010411491800_B36","first-page":"105","article-title":"Implementation of an automatic stop order and initial antibiotic exposure in very low birth weight infants","volume":"34","author":"Tolia","year":"2017","journal-title":"Am J Perinatol"},{"issue":"4","key":"2021121010411491800_B37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jpids\/piy043","article-title":"Antibiotic stewardship in the neonatal intensive care unit: effects of an automatic 48-hour antibiotic stop order on antibiotic use","volume":"8","author":"Astorga","year":"2019","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-051339\/1210813\/peds_2021051339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-051339\/1210813\/peds_2021051339.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T01:18:16Z","timestamp":1699838296000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/148\/6\/e2021051339\/183440\/Antibiotic-Use-in-Term-and-Near-Term-Newborns"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,12,1]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-051339","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"article-number":"e2021051339"}}